Current & Upcoming Initiatives
Active research. Growing evidence. Better outcomes.
Active Research Partnerships
Each partnership is designed to answer specific clinical and operational questions about how the MyNavigator Platform performs in real-world oncology settings — generating the evidence that payers, health systems, and pharmaceutical partners need to make informed adoption decisions.
MedStar Health Breast Center
Current Initiative
Evaluating whether MyNavigator improves patient and caregiver satisfaction in a high-volume academic breast cancer center.
Wichita Urology — Advanced Prostate Cancer
Current Initiative
Exploring whether proactive symptom monitoring, ICC engagement, and AI-enabled education improve adherence and reduce administrative burden for rural prostate cancer patients.
Unite for Her — Metastatic Breast Cancer
Current Initiative
Testing whether targeted messaging and ICC-inclusive reminders drive greater use of supportive services among metastatic breast cancer patients.
Pfizer Advanced Solutions
Upcoming Initiative
Investigating whether adherence drivers differ between oral and IV oncology therapeutics to inform how MyNavigator can best support each.
Avident Health's research initiatives span breast cancer, prostate cancer, metastatic disease, and multi-therapeutic contexts. Each study is designed with rigorous clinical and operational questions to build the real-world evidence base needed for broad platform adoption. Our research partnerships reflect our commitment to continuous improvement — learning from every deployment to make MyNavigator more effective for patients, caregivers, and clinical teams alike.
Future Directions
Avident Health is continuously expanding its research pipeline across cancer types, payer partnerships, and pharmaceutical collaborations. Upcoming initiatives will deepen the real-world evidence base for MyNavigator, explore dyadic patient-caregiver interventions in geriatric oncology, and extend the platform into new therapeutic areas where adherence drives measurable clinical and economic outcomes. We welcome the opportunity to co-design research that advances cancer care and improves lives.
Explore a Partnership